Wilson Sonsini Goodrich & Rosati represented Dewpoint Therapeutics in the transaction. Dewpoint Therapeutics Inc., the leading biotechnology company that develops therapeutics by targeting biomolecular condensates, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represents Pacific Biosciences of California, Inc. on the transaction. Pacific Biosciences of California, Inc. (PacBio) (NASDAQ: PACB), a leading developer of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised IonQ on the transaction. IonQ (NYSE: IONQ), a leader in quantum computing, announced that it has reached a definitive agreement...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Socure on the transaction. Socure, the leading provider of artificial intelligence for digital identity verification, fraud prevention, and sanction screening,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Stripe on the transaction. Financial infrastructure platform Stripe confirmed that it is acquiring stablecoin infrastructure provider Bridge. The transaction, which...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Featurespace in the deal. Visa (NYSE: V) announced it has signed a definitive agreement to acquire Featurespace, a developer of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Syxsense on the transaction. Absolute Security, announced it acquired Syxsense, a provider of automated endpoint and vulnerability management. Financial terms...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aurora Innovation, Inc. on the offering, and Latham & Watkins advised the underwriters. Aurora Innovation, Inc. (Nasdaq: AUR), a self-driving...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Astranis on the transaction. Astranis announced the completion of a $200 million Series D funding round led by long-time investor...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Hyperplane on the transaction. Brazil-based Nubank (NU) announced it has agreed to acquire Hyperplane, a data intelligence company from Silicon...
You must be a Standard 1 Year member to access this content.
